Eledon Pharmaceuticals
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
19800 MacArthur Blvd Ste 250, Irvine, Ca...Phone Number
(949) 238-8090Website
www.eledon.comRevenue
-Stock Symbol
ELDNIndustry
About Eledon Pharmaceuticals
Eledon Pharmaceuticals, Inc. is focused on innovating immunomodulatory therapies for organ transplantation, aiming to enhance the longevity and quality of life for transplant recipients. Their lead compound, tegoprubart, targets the CD40 Ligand pathway to improve transplant outcomes and reduce the side effects associated with current immunosuppressive treatments. The company primarily serves kidney and islet cell transplant patients, addressing the long-standing challenges in transplant immunosuppression. Eledon's mission is encapsulated in their motto, 'One Transplant for Life,' emphasizing their commitment to transforming the transplant experience.Explore more
Eledon Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Eledon Pharmaceuticals
Compare insights from companies similar to Eledon Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Eledon Pharmaceuticals Tech Stack
A closer look at the technologies used by Eledon Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eledon Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Eledon Pharmaceuticals, Inc. is focused on innovating immunomodulatory therapies for organ transplantation, aiming to enhance the longevity and quality of life for transplant recipients. Their lead compound, tegoprubart, targets the CD40 Ligand pathway to improve transplant outcomes and reduce the side effects associated with current immunosuppress... Read More
